Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine
Reference28 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2020 report. Available from: http://www.goldcopd.org. Accessed March 11, 2020.
2. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
3. Prevalence and Burden of Dyspnoea Among Patients with Chronic Obstructive Pulmonary Disease in Five European Countries
4. Lonhala® Magnair® [prescribing information]. Lonhala® Magnair® [prescribing information]. Marlborough, MA: Sunovion Pharmaceuticals Inc; June 2019.
5. In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献